These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2994910)

  • 21. Sodium fluoride stimulates osteocalcin in normal subjects.
    Dandona P; Coumar A; Gill DS; Bell J; Thomas M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):437-41. PubMed ID: 3266960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal parathyroid function in the X-linked hypophosphatemic mouse.
    Posillico JT; Lobaugh B; Muhlbaier LH; Drezner MK
    Calcif Tissue Int; 1985 Jul; 37(4):418-22. PubMed ID: 3930040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Clark AG; Drezner MK
    Calcif Tissue Int; 1982 Mar; 34(2):125-30. PubMed ID: 6282408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum parathyroid hormone in X-linked hypophosphatemia.
    Arnaud C; Glorieux F; Scriver C
    Science; 1971 Aug; 173(3999):845-7. PubMed ID: 5315247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of X-linked hypophosphatemic rickets.
    Chung WT; Niu DM; Lin CY
    Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.
    Eicher EM; Southard JL; Scriver CR; Glorieux FH
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4667-71. PubMed ID: 188049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Harrelson JM; Drezner MK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
    [No Abstract]   [Full Text] [Related]  

  • 31. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
    Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major.
    Dandona P; Menon RK; Houlder S; Thomas M; Hoffbrand AV; Flynn DM
    Arch Dis Child; 1987 May; 62(5):474-7. PubMed ID: 3496858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
    Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum osteocalcin radioimmunoassay in bone diseases.
    Galli M; Nuti R; Franci B; Righi G; Martorelli MT; Turchetti V; Caniggia M
    Ric Clin Lab; 1985; 15(3):253-7. PubMed ID: 3878567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
    Bettinelli A; Bianchi ML; Mazzucchi E; Gandolini G; Appiani AC
    J Pediatr; 1991 Mar; 118(3):372-6. PubMed ID: 1847972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired hypophosphataemic vitamin D resistant rickets in black children.
    Pettifor JM; Ross FP; Quirk M; Moodley GP; Cavaleros M
    Bone Miner; 1986 Sep; 1(4):307-19. PubMed ID: 2849486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Untreated hypophosphatemic vitamin D-resistant rickets with symptomatic ossification of the ligamentum flavum.
    Matsui H; Katoh Y; Tsuji H
    J Spinal Disord; 1991 Mar; 4(1):110-3. PubMed ID: 1666964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A sporadic case of vitamin D-resistant rickets in an adult].
    Chiesa A; Barbera G; Scassa E
    Minerva Med; 1983 Feb; 74(6):255-60. PubMed ID: 6298662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.